JP2005538690A5 - - Google Patents

Download PDF

Info

Publication number
JP2005538690A5
JP2005538690A5 JP2003571309A JP2003571309A JP2005538690A5 JP 2005538690 A5 JP2005538690 A5 JP 2005538690A5 JP 2003571309 A JP2003571309 A JP 2003571309A JP 2003571309 A JP2003571309 A JP 2003571309A JP 2005538690 A5 JP2005538690 A5 JP 2005538690A5
Authority
JP
Japan
Prior art keywords
ptx3
seq
derivative
tumor
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003571309A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005538690A (ja
Filing date
Publication date
Priority claimed from IT2002RM000109A external-priority patent/ITRM20020109A1/it
Application filed filed Critical
Publication of JP2005538690A publication Critical patent/JP2005538690A/ja
Publication of JP2005538690A5 publication Critical patent/JP2005538690A5/ja
Pending legal-status Critical Current

Links

JP2003571309A 2002-02-28 2003-02-25 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンptx3機能性誘導体 Pending JP2005538690A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000109A ITRM20020109A1 (it) 2002-02-28 2002-02-28 Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
PCT/IT2003/000104 WO2003072603A2 (en) 2002-02-28 2003-02-25 Long pentraxin ptx3 functional derivatives for preparing an autologous vaccine for the treatment of tumours

Publications (2)

Publication Number Publication Date
JP2005538690A JP2005538690A (ja) 2005-12-22
JP2005538690A5 true JP2005538690A5 (https=) 2006-04-06

Family

ID=11456119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003571309A Pending JP2005538690A (ja) 2002-02-28 2003-02-25 腫瘍の治療用の自己ワクチンの調製のための長いペントラキシンptx3機能性誘導体

Country Status (12)

Country Link
US (1) US20090110666A1 (https=)
EP (1) EP1478661A2 (https=)
JP (1) JP2005538690A (https=)
KR (1) KR20040099291A (https=)
AR (1) AR038854A1 (https=)
AU (1) AU2003214645A1 (https=)
CA (1) CA2475526A1 (https=)
IT (1) ITRM20020109A1 (https=)
MX (1) MXPA04008217A (https=)
PL (1) PL372719A1 (https=)
TW (1) TWI293958B (https=)
WO (1) WO2003072603A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040858A1 (it) 2004-04-29 2004-07-29 Farma Dev S R L Anticorpi monoclonali ibridomi metodo migliorato per determinare la proteina ptx3 e kit per detta determinazione
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
JP5427415B2 (ja) * 2006-01-24 2014-02-26 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ Fgf2結合性ペプチドおよびそれらの使用
US9226960B2 (en) 2010-04-16 2016-01-05 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
US8435525B1 (en) * 2010-04-16 2013-05-07 Andrew B. Bush FGF modulation of in vivo antibody production and humoral immunity
TWI531375B (zh) 2015-05-29 2016-05-01 國立成功大學 抑制癌細胞活性之短肽治療劑及含此之醫藥組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849478A (en) * 1986-08-14 1998-12-15 Cashman; Daniel P. Blocked-polymerase polynucleotide immunoassay method and kit
US5290551A (en) * 1990-05-08 1994-03-01 Thomas Jefferson University Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
IT1317927B1 (it) * 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
IT1317930B1 (it) * 2000-11-08 2003-07-15 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patalogie associate ad una alterata attivazione
US20020122820A1 (en) * 2001-01-16 2002-09-05 Hildebrand William H. Soluble MHC artificial antigen presenting cells
US20040198655A1 (en) * 2001-08-03 2004-10-07 Alberto Mantovani Use of long pentraxin ptx3 for treating female infertility
US7041648B2 (en) * 2001-08-03 2006-05-09 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compositions and methods for treating female fertility
ITRM20020191A1 (it) * 2002-04-08 2003-10-08 Sigma Tau Ind Farmaceuti Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie tumorali associate ad una alterata att
US20040137544A1 (en) * 2002-10-31 2004-07-15 Roberto Latini PTX3 as an early prognostic indicator of cardiovascular and cerebrovascular pathologies
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
US20070023879A1 (en) * 2005-07-29 2007-02-01 Vinayak Pandey Single unit heat sink, voltage regulator, and package solution for an integrated circuit

Similar Documents

Publication Publication Date Title
JP7328187B2 (ja) がん及び感染症の治療方法並びに治療用組成物
JP5971945B2 (ja) カチオン性脂質の鏡像異性体による免疫応答の刺激
ES2283070T3 (es) Utilizacion de oligonucleotidos inmunoestimulantes para la prevencion o tratamiento del asma.
JP2004515202A5 (https=)
US20090285901A1 (en) Polyamino acid for use as adjuvant
JP2003502283A5 (https=)
JP2006020648A5 (https=)
HU227944B1 (en) Vaccines containing a saponin and a sterol
PT662000E (pt) Microparticulas transportando antigenes e a sua utilizacao para a inducao de respostas humorais ou celulares
JPH01279842A (ja) A型及びb型肝炎混合アジュバントワクチン
JP2024036364A (ja) I型インターフェロン遺伝子を刺激するための方法及びカチオン性脂質を含む組成物
JP2002531521A5 (https=)
JP2005538690A5 (https=)
KR20250140108A (ko) 호흡기 세포융합 바이러스 mRNA 백신
EP1758615A2 (en) Combination treatment of cancer with elicitor of gene product expression and gene-product targeting agent
CN108210510B (zh) 一种小干扰核酸药物组合物及其用途
JP2008308440A (ja) 癌治療用薬剤送達ビヒクルおよびその製造方法ならびにそれを用いた製剤
JP2002526380A (ja) 癌関連muc−1ムチン誘発免疫抑制の治療におけるmuc−1誘導体とその使用法
TWI293958B (en) Functional derivatives of the long pentraxin ptx3 for the preparation of an autologous vaccine for the treatment of tumours
JP2003503042A5 (https=)
US8883989B2 (en) Fractalkine binding polynucleotides and methods of use
BR112019011262A2 (pt) composição farmacêutica, métodos para induzir ou promover ativação de células t, para induzir ou promover uma resposta imune, para tratar câncer e para tratar uma infecção.
JP2004519452A5 (https=)
CN112089833A (zh) 一种普适性的CpG ODN纳米颗粒佐剂及其制备方法和应用
CN117797085B (zh) 一种自组装hbv多肽纳米颗粒凝胶疫苗及其应用